AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Oramed Pharmaceuticals Inc.

Foreign Filer Report Nov 18, 2025

6965_rns_2025-11-18_cd0c806c-7a88-46cb-b951-1ac278e4143e.htm

Foreign Filer Report

Open in Viewer

Opens in native device viewer

_________ false

����� ����������� ���� 2 381
ORAMED PHARMACEUTICALS INC
Corporation no: 980376008 12537
- - -
Israel Securities Authority Tel Aviv Stock Exchange C003 ( Public ) Reported via MAGNA: 18/11/2025
www.isa.gov.il www.tase.co.il Reference: 2025-02-088456 Time of broadcast: 09:44 09:44

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Form 8A

20251117_Form_8A_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 06/08/2024
Address: Avenue of the Americas 01185 , New York 10036   New York , USA Tel: 844-9672633 , 02-5660001 Fax: 02-5660004
E-mail address: [email protected]   Company site: www.oramed.com
Previous names of reporting entity:
Name of the Signatory: GABAY AVRAHAM Position of Signatory in the reporting corporation: CFO & Secretary Name of Employer Company:
Address: Mamilla 20 , Jerusalem 9414904 Telephone: 052-5779725 Facsimile: 02-5660004 E-mail: [email protected] 1
USA

Talk to a Data Expert

Have a question? We'll get back to you promptly.